Editorial: Aromatase inhibitors: Where now?

Jtubilee Editorial Electrocardiography then and now : where next ?

When the Cardiac Society of Great Britain and Ireland met for the first time its initial task was to set up a committee to define the best location for a single chest electrocardiograph lead. The recommendations were agreed with the American Heart Association and a joint report was published in both countries and republished in the first issue of the British Heart Journal.' At that time the ele...

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now.

Now Nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs), including nonselective nonaspirin NSAIDs and cyclooxygenase-2 selective (COX-2) inhibitors, are widely used for various arthritides and pain syndromes. Cyclooxygenase-2 inhibitors in particular have been an enormous financial success, with more than $5 billion in sales in the United States in 2003 (1). That market took a huge hit rec...

On - chip flow cytometry : where is it now & where is it going ? Editorial

Flow cytometry is a powerful, high-throughput, single-cell characterization and sorting tool, which has a unique capability to provide fast and quantitative analyses of individual cells and physical separation of cells of particular interest from other cells [1]. In flow cytometry, the cell analyses are performed by passing a narrow stream of cells through a focused laser beam at a rate of thou...

Adhesive small bowel obstruction: where do we stand now?

Adhesive small bowel obstruction (ASBO) is one of the most frequently encountered disorders in Emergency Surgery Departments worldwide without negligible hospital admission rates and social costs (1,2). Notwithstanding significant improvements in techniques and materials, intra-abdominal adhesions following abdominal surgery still represent a major unsolved and debated issue harbouring challeng...

The Battle Against COVID-19: Where Do We Stand Now?